Oura, the smart ring company known for its sleep tracking technology, is facing a class-action lawsuit filed by the Clarkson Law Firm in San Francisco. The complaint alleges that Oura misled consumers by falsely advertising the ring's ability to accurately measure sleep quality and stages. According to the lawsuit, the rings do not actually detect physiological signals required to track sleep stages but instead use AI-generated guesses with accuracy comparable to a coin flip. This legal action follows years of user complaints online expressing dissatisfaction with the sleep data provided by Oura’s devices.

The lawsuit criticizes Oura for marketing its rings as capable of delivering precise sleep stage insights typically available only through clinical sleep studies involving specialized equipment. Plaintiffs argue that advertising the ring as being “built for accuracy” and offering up to 95% sleep-staging accuracy is deceptive since the technology cannot genuinely pinpoint what happens in the brain during sleep. The complaint claims this misinformation is harmful as customers rely on these inaccurate readings to make important health decisions and adjust their daily routines.

In response, Oura defended its technology by emphasizing its reliance on multiple physiological signals such as heart rate variability, movement, breathing, and temperature to estimate sleep stages. The company states that its sleep tracking has been validated in various independent scientific studies comparing it favorably to the polysomnography gold standard used in clinical settings. However, Oura also acknowledges that its rings are not medical devices and should not replace professional sleep assessments.

The lawsuit seeks an injunction to stop Oura from continuing to make allegedly deceptive claims and requests restitution for consumers who purchased the products based on these claims. As the legal process unfolds, Oura has stated it will vigorously defend against the accusations in court while maintaining confidence in its research and technology. This case highlights ongoing challenges and scrutiny around the accuracy and marketing of consumer wearable health devices.